IGEN BIOLAB GROUP develops postbiotics to modify the microbiota. Technologies related to the modulation of microbiomes generate small molecules, biological peptides and bacterial strains that change the interactions of microorganisms with each other, and between the microorganisms and the host, which contribute to the state of health and / or disease. These technologies allow IGEN BIOLAB GROUP to identify key members of the microbial community, activities and metabolites and to analyse modulation potential against host targets of interest.”
These capabilities combine IGEN BIOLAB GROUP’s expertise in microbiome research with proprietary and licensed technology for -omics, computer resources, and in vitro and in vivo trials.
In our facilities we design and develop processes that allow us to obtain complex formulations, but with an easy application to modulate the microbiome.